Predicted to enable enzyme binding activity; glycosphingolipid binding activity; and integrin binding activity. Predicted to be an extracellular matrix structural constituent. Predicted to be involved in several processes, including basement membrane assembly; neurogenesis; and substrate adhesion-dependent cell spreading. Predicted to act upstream of or within embryo implantation and neuron projection development. Located in collagen-containing extracellular matrix. Human ortholog(s) of this gene implicated in autistic disorder and lissencephaly 5. Orthologous to human LAMB1 (laminin subunit beta 1).
RGD Description
Predicted to enable enzyme binding activity; glycosphingolipid binding activity; and integrin binding activity. Predicted to be a structural constituent of synapse-associated extracellular matrix. Predicted to be an extracellular matrix structural constituent. Predicted to be involved in several processes, including basement membrane assembly; neurogenesis; and substrate adhesion-dependent cell spreading. Predicted to act upstream of or within embryo implantation and neuron projection development. Located in collagen-containing extracellular matrix. Human ortholog(s) of this gene implicated in autistic disorder and lissencephaly 5. Orthologous to human LAMB1 (laminin subunit beta 1); INTERACTS WITH 17beta-estradiol 3-benzoate; 2,3,7,8-tetrachlorodibenzodioxine; 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine.